Clinical Trials Logo

Secondary Hyperoxaluria clinical trials

View clinical trials related to Secondary Hyperoxaluria.

Filter by:
  • Recruiting  
  • Page 1

NCT ID: NCT03346369 Recruiting - Nephrolithiasis Clinical Trials

Lanthanum Carbonate (Fosrenol®) to Reduce Oxalate Excretion in Patients With Secondary Hyperoxaluria and Nephrolithiasis

LaCa
Start date: August 18, 2017
Phase: Phase 3
Study type: Interventional

This study investigates the efficacy and the safety of Lanthanum Carbonate for the reduction of urinary oxalate excretion in patients with secondary hyperoxaluria and nephrolithiasis.